Christopher le, MD
Otolaryngology · Tucson, AZNPI 1679700801
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Synthes GmbH accounts for 62.4% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $3,180, more than ten times the $231 reported in 2019.
Across 36 payments — averaging $125.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes GmbH$3K
- Medtronic$513
- Stryker$334
- Sanofi$309
- Neurent Medical Limited$152
- Mentor Worldwide LLC$147
- plus $247 from 3 others
What the payments were for
- Consulting fees$1,50033%
- Travel & lodging$1,17626%
- Food & beverage$1,85141%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes GmbH | 5 | $2,823 |
| Medtronic(2 entities) | 19 | $513 |
| Stryker | 4 | $334 |
| Sanofi | 3 | $309 |
| Neurent Medical Limited | 1 | $152 |
| Mentor Worldwide LLC | 1 | $147 |
| Arrinex, Inc. | 1 | $117 |
| Regeneron Healthcare Solutions, Inc. | 1 | $100 |
| Averitas Pharma Inc. | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,527 in reported general payments places this provider in the 80th percentile of 150 otolaryngology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 58 | $3,357 |
| Tobramycin Sulfate | 19 | $2,936 |
| Azelastine Hcl | 68 | $2,395 |
| Gentamicin Sulfate | 12 | $1,870 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 11 | $1,399 |
| Mupirocin | 71 | $1,193 |
| Fluticasone Propionate | 51 | $977 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 54 | $817 |
| Ciprofloxacin Hcl | 35 | $492 |
| Doxycycline Hyclate | 32 | $449 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $123 |
| Methylprednisolone | 17 | $123 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Tucson
- Eugene ChangTucson$44K
- Shethal BearellyTucson$11K
- Afshin EmamiTucson$8K
- Matthew GroysmanTucson$6K
- Adam RayTucson$5K
- John ChastainTucson$4K
- Robert DeanTucson$4K
- David HuTucson$4K
- Claire GleadhillTucson$3K
- Austin LeverTucson$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.